Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Deep Phenotyping Platform to Develop a Novel Retinal Imaging Test for Coronary Artery Disease: A Prospective Cross-Sectional Study

NCT05199428 is registered in ClinicalTrials.gov with Optina Diagnostics Inc. as lead sponsor.

NCT NCT05199428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05199428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Deep Phenotyping Platform to Develop a Novel Retinal Imaging Test for Coronary Artery Disease: A Prospective Cross-Sectional Study
Lead sponsor
Optina Diagnostics Inc.
Phase
Observational
Overall status
Completed
Start date
June 15, 2022
Completion date
March 22, 2024
Enrollment
308 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease